New drug targets Alzheimer's proteins in spinal fluid
NCT ID NCT07598370
First seen May 21, 2026 · Last updated Jun 14, 2026 · Updated 3 times
Summary
This early-stage study tests a new drug, LY3439539, in 30 people with mild-to-moderate Alzheimer's. The main goal is to see how the drug changes certain proteins in the spinal fluid that are linked to Alzheimer's. Participants will have monthly visits over about 9 months. This study does not aim to cure or treat symptoms, but to learn how the drug affects the body.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Austin Health - Heidelberg Repatriation Hospital
Ivanhoe, 3079, Australia
Contact Phone: •••-•••-••••
Contact
-
Flinders Medical Centre
Adelaide, 5042, Australia
Contact Phone: •••-•••-••••
Contact
-
Lilly Centre for Clinical Pharmacology
Singapore, 138623, Singapore
Contact Phone: •••-•••-••••
Contact
-
Macquarie University Hospital
Macquarie University, 2109, Australia
Contact Phone: •••-•••-••••
Contact
-
Southern Neurology
Kogarah, 2217, Australia
Contact Phone: •••-•••-••••
Contact
-
The Alfred
Melbourne, 3004, Australia
Contact Phone: •••-•••-••••
Contact
-
University of the Sunshine Coast Clinical Trial Centre
Birtinya, 4575, Australia
Contact Phone: •••-•••-••••
Contact
Conditions
Explore the condition pages connected to this study.